STAT1 and neoplasm: In the study by Chan et al. 45% (37/83) of ER+ tumors and 22% (17/78) of ER− tumors showed low IHC expression of STAT1 compared to adjacent peri-tumoral tissues, suggesting that loss of STAT1 expression is involved in tumor progression [114].